Use of intravenous cangrelor in the treatment of ruptured and unruptured cerebral aneurysms: an updated single-center analysis and pooled analysis of current studies

Conclusions
IV cangrelor during aneurysm embolization appears to be safe, with a symptomatic intracranial hemorrhage rate of 4% in ruptured cases and 2.6% in unruptured cases. More research is needed to determine the ideal dosing regimen.

Source: Journal of NeuroInterventional Surgery - June 16, 2023 Category: Neurosurgery Authors: Entezami, P., Dalfino, J. C., Boulos, A. S., Yamamoto, J., Holden, D. N., Field, N. C., Rock, A. K., Najera, E., Paul, A. R. Tags: New devices New devices and techniques Source Type: research